Immatics GAAP EPS of -Euro1.61, revenue of Euro48.2M
Source: SeekingAlpha
2026-03-05 16:58:56 ET
More on Immatics
- Immatics: PRAME Leader's Transition To Commercial Reality
- Seeking Alpha’s Quant Rating on Immatics
- Historical earnings data for Immatics
- Financial information for Immatics
Read the full article on Seeking Alpha
For further details see:
Immatics GAAP EPS of -€1.61, revenue of €48.2M
Immatics N.V.
NASDAQ: IMTX
IMTX Trading
-2.95% G/L:
$9.20 Last:
119,290 Volume:
$9.52 Open:
IMTX Latest News
February 05, 2026 08:32:00 am
Big Pharma's $170B Panic: Why Capital Is Rotating to Clinical Stage Oncology
IMTX Stock Data
$1,341,978,928
63,814,383
N/A
32
N/A
Biotechnology & Life Sciences
Healthcare
DE
Tbingen
